Cohort profile: the Emory Cardiovascular Biobank (EmCAB)
Open Access
Abstract
Purpose The Emory Cardiovascular Biobank (EmCAB) is an ongoing prospective registry of patients undergoing cardiac catheterisation, which was established to identify novel factors associated with the pathobiological process and treatment of cardiovascular disease. Participants Individuals aged 18 years and older undergoing cardiac catheterisation at three Emory Healthcare sites in Atlanta are asked to participate in this prospective registry. Around 95% agree to participate. Around 7000 unique patients have been enrolled. The current data set contains detailed phenotyping, patient outcomes, genomics, protein biomarkers, regenerative markers, transcriptomic analysis, metabolomics profiling and longitudinal follow-up for adverse cardiovascular outcomes. Findings to date Thus far, the EmCAB has approximately 3000 major cardiovascular events. About 48% of the EmCAB participants have more than 5 years of follow-up. It is a great resource for discovery of novel predictive factors for cardiovascular disease outcomes, including genomics, transcriptomics, protein biomarkers, oxidative stress markers and circulating progenitor cells. Several circulating inflammatory markers have shown to improve risk prediction metrics beyond standard risk factors. Future plans Future integrative –omics analyses will provide the cardiovascular research community opportunities for subsequent mechanistic confirmation studies, which will promote the development of effective personalised therapy that leads to clinical care tailored to the individual patient.Keywords
This publication has 30 references indexed in Scilit:
- Risk Factors of Coronary Artery Disease in Secondary Prevention—Results from the AtheroGene—StudyPLOS ONE, 2015
- Predictive Value of Updating Framingham Risk Scores with Novel Risk Markers in the U.S. General PopulationPLOS ONE, 2014
- xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics dataBMC Bioinformatics, 2013
- The chromosome 9p21 risk locus is associated with angiographic severity and progression of coronary artery diseaseEuropean Heart Journal, 2010
- apLCMS—adaptive processing of high-resolution LC/MS dataBioinformatics, 2009
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- Contribution of changes in incidence and mortality to trends in the prevalence of coronary heart disease in the UK: 1996 2005European Heart Journal, 2007
- The Economic Burden of Chronic Cardiovascular Disease for Major InsurersHealth Promotion Practice, 2007
- Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000New England Journal of Medicine, 2007
- Factors of Risk in the Development of Coronary Heart Disease—Six-Year Follow-up ExperienceAnnals of Internal Medicine, 1961